ROPEGINTERFERON ALFA-2B
ROPEGINTERFERON ALFA-2B is listed in the FDA National Drug Code directory with 5 NDC codes, marketed under brand names including BESREMi, BESREMi Pen. Available dosage forms: injection, injection, solution.
Drug details
- Generic Name
- ROPEGINTERFERON ALFA-2B
- Brand Names
- BESREMi, BESREMi Pen
- Application Number
- BLA761166
- Sponsor
- PharmaEssentia USA
- NDC Codes
- 5
- Dosage Forms
- INJECTION, INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- ROPEGINTERFERON ALFA-2B
Indications and Usage
1 INDICATIONS AND USAGE BESREMi is an interferon alfa-2b indicated for: • The treatment of adults with essential thrombocythemia. ( 1.1 ) • The treatment of adults with polycythemia vera. ( 1.2 ) 1.1 Essential Thrombocythemia BESREMi is indicated for the treatment of adults with essential thrombocythemia. 1.2 Polycythemia Vera BESREMi is indicated for the treatment of adults with polycythemia vera.